Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease

被引:22
作者
Azuma, Minako [1 ]
Hirai, Toshinori [1 ]
Nakaura, Takeshi [2 ]
Kitajima, Mika [2 ]
Yamashita, Satoshi [3 ]
Hashimoto, Mamoru [4 ]
Yamada, Kazumichi [5 ]
Uetani, Hiroyuki [2 ]
Yamashita, Yasuyuki [2 ]
Wang, Yi [6 ]
机构
[1] Univ Miyazaki, Fac Med, Dept Radiol, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Kumamoto, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan
[4] Osaka Univ, Dept Behav Neurol & Neuropsychiat, United Grad Sch Child Dev, Osaka, Japan
[5] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Kumamoto, Japan
[6] Weill Cornell Med Coll, Dept Radiol, New York, NY USA
关键词
Quantitative susceptibility mapping; MRI; Progressive supranuclear palsy; Parkinson's disease; BRAIN IRON DEPOSITION; SUBSTANTIA-NIGRA; DIAGNOSIS; VALIDATION; FERRITIN; CRITERIA; VARIANT; QSM;
D O I
10.1016/j.jns.2019.116443
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To determine whether the susceptibility value in the deep gray matter obtained by quantitative susceptibility mapping (QSM) provides additive value to the morphometric index for differentiating progressive supranuclear palsy (PSP) from Parkinson's disease (PD). Materials and methods: PSP- (n = 8) and PD patients (n = 18) and 18 age-matched healthy controls who underwent QSM and 3D magnetization-prepared rapid gradient echo (MPRAGE) sequences. The mean susceptibility values (MSVs) of the deep gray matter structures on QSM- and areas of the midbrain (morphometric index, MI) on 3D MPRAGE images were measured by two neuroradiologists. Analysis of variance, the Scheffe test and receiver operating characteristic (ROC) analysis were conducted to assess differences and discriminate among PSP, PD and controls by the MSVs and the MI. Using the MSV of a structure with the best area under the curve (AUC) and the MI, we created a decision tree to differentiate between PSP and PD. Results: The MSVs of the globus pallidus (GP) and substantia nigra (SN) were significantly higher in PSP than PD and the controls (p < .05). By ROC analysis (PSP vs PD), AUC was greatest (0.903) for the GP. The MI was significantly smaller in PSP than PD and the controls (p < .05); AUC (PSP vs PD) was 0.917. The decision tree using cutoff values of 244 parts per billion for MSV of the GP and 74.0 mm(2) for MI served to completely differentiate between PSP and PD. Conclusion: The MSV in the GP on QSM images adds value to the MI for differentiating PSP from PD.
引用
收藏
页数:6
相关论文
共 25 条
[1]   Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping [J].
Azuma, M. ;
Hirai, T. ;
Yamada, K. ;
Yamashita, S. ;
Ando, Y. ;
Tateishi, M. ;
Iryo, Y. ;
Yoneda, T. ;
Kitajima, M. ;
Wang, Y. ;
Yamashita, Y. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (05) :782-788
[2]   Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy [J].
Bacchi, Stephen ;
Chim, Ivana ;
Patel, Sandy .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2018, 62 (01) :21-31
[3]   Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches [J].
Boxer, Adam L. ;
Yu, Jin-Tai ;
Golbe, Lawrence I. ;
Litvan, Irene ;
Lang, Anthony E. ;
Hoeglinger, Guenter U. .
LANCET NEUROLOGY, 2017, 16 (07) :552-563
[4]   Clinical differentiation of parkinsonian syndromes: Prognostic and therapeutic relevance [J].
Christine, CW ;
Aminoff, MJ .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (06) :412-419
[5]   INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
WELLS, FR ;
LEES, AJ ;
AGID, F ;
AGID, Y ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836
[6]   ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE-METALS IN PARKINSONS-DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA [J].
DEXTER, DT ;
CARAYON, A ;
JAVOYAGID, F ;
AGID, Y ;
WELLS, FR ;
DANIEL, SE ;
LEES, AJ ;
JENNER, P ;
MARSDEN, CD .
BRAIN, 1991, 114 :1953-1975
[7]  
Dormont D, 2004, AM J NEURORADIOL, V25, P1516
[8]   Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence [J].
Graham, JM ;
Paley, MNJ ;
Grünewald, RA ;
Hoggard, N ;
Griffiths, PD .
BRAIN, 2000, 123 :2423-2431
[9]   Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy [J].
Han, Yong-Hee ;
Lee, Jae-Hyeok ;
Kang, Bok-Man ;
Mun, Chi-Woong ;
Baik, Seung-Kug ;
Shin, Yong-il ;
Park, Kyu-Hyun .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 325 (1-2) :29-35
[10]   IRON CONCENTRATION REDUCED IN VENTRAL PALLIDUM, GLOBUS PALLIDUS, AND SUBSTANTIA NIGRA BY GABA-TRANSAMINASE INHIBITOR, GAMMA-VINYL GABA [J].
HILL, JM .
BRAIN RESEARCH, 1985, 342 (01) :18-25